前盆腔器官脱垂初次手术治疗的系統评价、网状Meta分析与成本效果分析
该系统评价纳入27项随机对照试验、涉及3194名女性、8种手术方式,网状Meta分析显示合成网片在预防同部位复发方面最有效,但成本效用分析表明非网片修补具有最高成本效果概率,作者认为网片增强的前壁修补在初次前盆腔器官脱垂修复中看似不具有成本效果。
要点
- 合成网片在预防前盆腔器官脱垂同部位复发方面最有效。
- 非网片修补具有最高的成本效果概率。
- 作者认为网片增强前壁修补在初次修复中看似不具有成本效果。
核心结论
- 作者认为,对于需要初次修复前盆腔器官脱垂的女性,网片增强的前壁修补看似不具有成本效果。
研究设计与样本
- 系统评价与网状Meta分析纳入27项符合条件的随机对照试验,涉及8种手术治疗、共3194名女性。
- 采用马尔可夫模型从英国国家卫生服务体系视角比较初次前盆腔器官脱垂修复手术的成本效用。
主要发现
- 合成网片在预防同部位复发方面最有效。
- 没有证据提示合成不可吸收网片、合成部分可吸收网片与生物网片之间存在差异。
- 纳入有效性、并发症和成本数据的成本效用分析发现,非网片修补具有最高的成本效果概率。
- 上述结论对模型输入(包括有效性、成本和效用值)稳健。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要进一步研究网片产品的长期有效性和安全性,以更大确定性确立其相对成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anterior compartment prolapse is the most common pelvic organ prolapse (POP) with a range of surgical treatment options available. OBJECTIVES: To compare the clinical effectiveness and cost-effectiveness of surgical treatments for the repair of anterior POP. METHODS: We conducted a systematic review of randomised controlled trials comparing surgical treatments for women with POP. Network meta-analysis was possible for anterior POP, same-site recurrence outcome. A Markov model was used to compare the cost-utility of surgical treatments for the primary repair of anterior POP from a UK National Health Service perspective. MAIN RESULTS: We identified 27 eligible trials for the network meta-analysis involving eight surgical treatments tested on 3194 women. Synthetic mesh was the most effective in preventing recurrence at the same site. There was no evidence to suggest a difference between synthetic non-absorbable mesh, synthetic partially absorbable mesh, and biological mesh. The cost-utility analysis, which incorporated effectiveness, complications and cost data, found non-mesh repair to have the highest probability of being cost-effective. The conclusions were robust to model inputs including effectiveness, costs and utility values. CONCLUSIONS: Anterior colporrhaphy augmented with mesh appeared to be cost-ineffective in women requiring primary repair of anterior POP. There is a need for further research on long-term effectiveness and the safety of mesh products to establish their relative cost-effectiveness with a greater certainty. TWEETABLE ABSTRACT: New study finds mesh cost-ineffective in women with anterior pelvic organ prolapse.
引用
- Slade E, Daly C, Mavranezouli I, et al. Primary surgical management of anterior pelvic organ prolapse: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG. 2019. PMID: 31538709. doi:10.1111/1471-0528.15959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。